1. Home
  2. WVE
  3. WVE News

Latest Wave Life Sciences Ltd. (WVE) News on June 7, 2025

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
WVE

GlobeNewswire

9 days ago

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
WVE

GlobeNewswire

10 days ago

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer

Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now?
WVE

Insider Monkey

25 days ago

Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now?

Wave Life Sciences First Quarter 2025 Earnings: Misses Expectations
WVE

Simply Wall St.

a month ago

Wave Life Sciences First Quarter 2025 Earnings: Misses Expectations

WVE

MT Newswires

a month ago

RBC Cuts Price Target on Wave Life Sciences to $9 From $10, Keeps Sector Perform, Speculative Risk

WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ...
WVE

GuruFocus.com

a month ago

WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ...

Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates
WVE

Zacks

a month ago

Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates

WVE

Associated Press Finance

a month ago

Wave Life Sciences: Q1 Earnings Snapshot

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
WVE

GlobeNewswire

a month ago

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

WAVE Life Sciences Ltd (WVE) Q1 2025: Everything You Need To Know Ahead Of Earnings
WVE

GuruFocus.com

a month ago

WAVE Life Sciences Ltd (WVE) Q1 2025: Everything You Need To Know Ahead Of Earnings

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for
WVE

Zacks

a month ago

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for

Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
WVE

GlobeNewswire

a month ago

Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025

WVE

MT Newswires

a month ago

Cantor Fitzgerald Initiates Wave Life Sciences at Overweight With $10 Price Target

Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?
WVE

Simply Wall St.

2 months ago

Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?

WVE

MT Newswires

2 months ago

B. Riley Adjusts Wave Life Sciences' Price Target to $19 From $22, Keeps Buy Rating

WVE

MT Newswires

2 months ago

Wedbush Initiates Wave Life Sciences at Outperform With $18 Price Target

WVE

MT Newswires

2 months ago

RBC Cuts Price Target on Wave Life Sciences to $10 From $14, Keeps Sector Perform, Speculative Risk

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics
WVE

Zacks

2 months ago

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Promising Genomics & Synthetic Biology Stocks to Consider in 2025
WVE

Zacks

2 months ago

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531
WVE

Clinical Trials Arena

2 months ago

Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531

Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar?
WVE

Zacks

2 months ago

Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar?

WVE

MT Newswires

2 months ago

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

WVE

MT Newswires

2 months ago

Wave Life Sciences Reports 'Positive' Data for Prospective Duchenne Treatment; Shares Up Pre-Bell

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
WVE

GlobeNewswire

2 months ago

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531

Wave to seek approval of Duchenne drug after mid-stage study data
WVE

BioPharma Dive

2 months ago

Wave to seek approval of Duchenne drug after mid-stage study data

Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains?
WVE

Zacks

3 months ago

Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains?

WVE

MT Newswires

3 months ago

RBC Trims Price Target on Wave Life Sciences to $14 From $15, Keeps Sector Perform, Speculative Risk

Wave Life Sciences Full Year 2024 Earnings: Beats Expectations
WVE

Simply Wall St.

3 months ago

Wave Life Sciences Full Year 2024 Earnings: Beats Expectations

WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Clinical ...
WVE

GuruFocus.com

3 months ago

WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Clinical ...

WVE

MT Newswires

3 months ago

Sector Update: Health Care Stocks Mixed Premarket Tuesday

WVE

MT Newswires

3 months ago

Wave Life Sciences Swings to Q4 Earnings, Revenue Rises

WVE

Associated Press Finance

3 months ago

Wave Life Sciences: Q4 Earnings Snapshot

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
WVE

GlobeNewswire

3 months ago

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Earnings To Watch: WAVE Life Sciences Ltd (WVE) Reports Q4 2024 Result
WVE

GuruFocus.com

3 months ago

Earnings To Watch: WAVE Life Sciences Ltd (WVE) Reports Q4 2024 Result

Will Foghorn Therapeutics Inc. (FHTX) Report Negative Q4 Earnings? What You Should Know
WVE

Zacks

3 months ago

Will Foghorn Therapeutics Inc. (FHTX) Report Negative Q4 Earnings? What You Should Know

Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025
WVE

GlobeNewswire

3 months ago

Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025

What Makes Wave Life Sciences Ltd. (WVE) an Investment Bet?
WVE

Insider Monkey

4 months ago

What Makes Wave Life Sciences Ltd. (WVE) an Investment Bet?

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
WVE

GlobeNewswire

4 months ago

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity

Wave Life Sciences (NASDAQ:WVE) shareholders have earned a 69% CAGR over the last three years
WVE

Simply Wall St.

4 months ago

Wave Life Sciences (NASDAQ:WVE) shareholders have earned a 69% CAGR over the last three years

Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential?
WVE

Insider Monkey

5 months ago

Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential?

Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation
WVE

GlobeNewswire

5 months ago

Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation

Is Wave Life Sciences Ltd. (WVE) the Best Growth Stock to Buy Now Under $25?
WVE

Insider Monkey

5 months ago

Is Wave Life Sciences Ltd. (WVE) the Best Growth Stock to Buy Now Under $25?

WVE

MT Newswires

5 months ago

Wave Life Sciences Files Clinical Trial Application for WVE-007 To Treat Obesity

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity
WVE

GlobeNewswire

5 months ago

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity

Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
WVE

GlobeNewswire

6 months ago

Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Wave Life Sciences to Present at Upcoming Investor Conferences
WVE

GlobeNewswire

6 months ago

Wave Life Sciences to Present at Upcoming Investor Conferences

Wave Life Sciences to Present at Jefferies London Healthcare Conference
WVE

GlobeNewswire

7 months ago

Wave Life Sciences to Present at Jefferies London Healthcare Conference

Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20
WVE

Simply Wall St.

7 months ago

Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations
WVE

Simply Wall St.

7 months ago

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations

WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
WVE

GuruFocus.com

7 months ago

WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

WVE

MT Newswires

7 months ago

--Truist Securities Adjusts Price Target on Wave Life Sciences to $36 From $17, Keeps Buy Rating

Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates
WVE

Zacks

7 months ago

Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates

WVE

MT Newswires

7 months ago

Wave Life Sciences Swings to Q3 Loss

WVE

Associated Press Finance

7 months ago

Wave Life Sciences: Q3 Earnings Snapshot

Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
WVE

GlobeNewswire

7 months ago

Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update

WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of Earnings
WVE

GuruFocus.com

7 months ago

WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of Earnings

Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy?
WVE

Zacks

7 months ago

Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy?

Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
WVE

GlobeNewswire

7 months ago

Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024

WVE

MT Newswires

7 months ago

B. Riley Adjusts Wave Life Sciences' Price Target to $22 From $19, Maintains Buy Rating

Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them.
WVE

Simply Wall St.

7 months ago

Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them.

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
WVE

GlobeNewswire

7 months ago

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs

How to play biotech stocks: Insmed and Wave Life Sciences
WVE

Yahoo Finance Video

7 months ago

How to play biotech stocks: Insmed and Wave Life Sciences

Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know
WVE

Zacks

7 months ago

Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know

1 Brand-New Big Reason to Buy This Biotech Stock Right Now
WVE

Motley Fool

7 months ago

1 Brand-New Big Reason to Buy This Biotech Stock Right Now

What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now?
WVE

Zacks

7 months ago

What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now?

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
WVE

Investor's Business Daily

8 months ago

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.

WVE

MT Newswires

8 months ago

RBC Boosts Price Target on Wave Life Sciences to $15 From $7, Keeps Sector Perform, Speculative Risk

Wave Life Sciences Shares Surge After RNA Editing Discovery
WVE

GuruFocus.com

8 months ago

Wave Life Sciences Shares Surge After RNA Editing Discovery

WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data
WVE

Zacks

8 months ago

WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data

Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last?
WVE

Zacks

8 months ago

Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last?

WVE

MT Newswires

8 months ago

Raymond James Upgrades Wave Life Sciences to Strong Buy From Outperform, Price Target is $22

Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.
WVE

Investor's Business Daily

8 months ago

Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.

RNA-Editing Stocks Soar by Record on Wave Life’s Trial Data
WVE

Bloomberg

8 months ago

RNA-Editing Stocks Soar by Record on Wave Life’s Trial Data

WVE

MT Newswires

8 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

WVE

MT Newswires

8 months ago

Sector Update: Health Care

WVE

MT Newswires

8 months ago

Top Midday Gainers

Wave Life Sciences Stock Climbs on RNA Editing Progress
WVE

The Wall Street Journal

8 months ago

Wave Life Sciences Stock Climbs on RNA Editing Progress

WVE

MT Newswires

8 months ago

Update: Wave Life Sciences Shares Soar After Reporting Positive Proof-of-Mechanism Data From WVE-006 Study

WVE

MT Newswires

8 months ago

Wave Life Sciences Reports Positive Proof-of-Mechanism Data From WVE-006 Study; Shares Surge 32% Pre-Bell

GSK Bought More Shares of Biotech Wave Life Sciences
WVE

Barrons.com

8 months ago

GSK Bought More Shares of Biotech Wave Life Sciences

How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71%
WVE

Zacks

8 months ago

How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71%

WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...
WVE

GuruFocus.com

8 months ago

WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...

WVE

MT Newswires

8 months ago

RBC Raises Price Target on WAVE Life Sciences to $7 From $5, Keeps Sector Perform Rating, Speculative Risk

WVE

MT Newswires

8 months ago

B. Riley Adjusts WAVE Life Sciences' PT to $19 From $11, Maintains Buy Rating

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
WVE

Motley Fool

8 months ago

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

WVE

MT Newswires

8 months ago

Wave Life Sciences Closes $230 Million Sale of Shares, Warrant

Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
WVE

GlobeNewswire

8 months ago

Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
WVE

GlobeNewswire

8 months ago

Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
WVE

Zacks

8 months ago

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More

WVE

MT Newswires

8 months ago

Wave Life Sciences Prices $200 Million Public Offering

Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
WVE

GlobeNewswire

8 months ago

Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

WVE Stock Soars on Upbeat Efficacy Data From Muscle Disease Study
WVE

Zacks

8 months ago

WVE Stock Soars on Upbeat Efficacy Data From Muscle Disease Study

Wave’s stock swells as it eyes approval following Phase II DMD victory
WVE

Clinical Trials Arena

8 months ago

Wave’s stock swells as it eyes approval following Phase II DMD victory

WVE

MT Newswires

8 months ago

Wave Life Sciences Discloses Planned Offering of Shares, Warrants

WVE

MT Newswires

8 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
WVE

GlobeNewswire

8 months ago

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

WVE

MT Newswires

8 months ago

Sector Update: Health Care Stocks Decline Tuesday Afternoon

WVE

MT Newswires

8 months ago

Top Midday Gainers

WVE

MT Newswires

8 months ago

Wave Life Sciences Shares Soar After 'Positive' Data on Duchenne Muscular Dystrophy Drug Trial

WVE

MT Newswires

8 months ago

HC Wainwright Adjusts Price Target on WAVE Life Sciences to $22 From $15, Maintains Buy Rating

Share on Social Networks: